SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

PL4 - Clinical Trials Plenary Session

Event Time: Tuesday April 25, 2017 9:15 am to 11:30 am
Topic(s): Aging, Dementia, Cognitive, and Behavioral Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), Headache, MS and CNS Inflammatory Disease, Neuromuscular and Clinical Neurophysiology (EMG)
Director(s):
Description: This session covers important clinical topics identified from other society meetings that affect patient care. The latest updates within several clinical trials conducted over the course of the last year will be presented.
Completion Message:
CME Credits: 2.25
Core Competencies:

Program Speakers - Tentative

Start/End Time Title Faculty
9:15 AM - 9:30 AM Effect of Intensive Systolic Blood Pressure Lowering on Hematoma Expansion in Patients with Intracerebral Hemorrhage: Analysis of Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II Trial Joshua Goldstein  
9:30 AM - 9:45 AM Longitudinal Effect of Eteplirsen Versus Historical Control on Ambulation in Duchenne Muscular Dystrophy Jerry Mendell MD, FAAN 
9:45 AM - 10:00 AM Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine Scott Powers PhD 
10:00 AM - 10:15 AM Efficacy of Siponimod in Secondary Progressive Multiple Sclerosis: Results of the Phase 3 Study Ludwig Kappos MD, FAAN 
10:15 AM - 10:30 AM A 2-year Multidomain Intervention of Diet, Exercise, Cognitive Training, and Vascular Risk Monitoring Versus Control to Prevent Cognitive Decline in At-risk Elderly People (FINGER): A Randomized Controlled Trial Miia Kivipelto MD 
10:30 AM - 10:45 AM AVXS-101 Phase 1 Gene Therapy Clinical Trial in SMA Type 1: Event Free Survival and Achievement of Developmental Milestones Jerry Mendell MD, FAAN 
10:45 AM - 11:00 AM Cannabidiol (CBD) Reduces Convulsive Seizure Frequency in Dravet Syndrome: Results of a Multi-Center, Randomized, Controlled Trial (GWPCARE1) J. Helen Cross  
11:00 AM - 11:15 AM MGTX: Results of the Multinational Thymectomy Trial in Non-thymomatous Myasthenia Gravis Gil Wolfe MD, FAAN 
11:15 AM - 11:30 AM Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention: Primary Results of the STRIVE Trial Peter Goadsby MD, PhD 

Disclosures

Speaker Disclosure
J. Helen Cross Patent applications are submitted for a C10 preparation Betasht, with UCL/Royal Holloway and Vitaflo. Research support from Vitaflo – clinical trial Betashot in epilepsy Chief Investigator UK GW Pharma Study and local PI, CBD in DRavt syndrome and Lennox Gastaut Syndrome PI Fenfluramine in Dravet syndrome All remuneration to the department Vitaflo – clinical trial Betashot in.

Peter Goadsby, MD, PhD Dr. Goadsby has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Alder Biopharmaceuticals, Allergan, Amgen, Electrocore, Eli-Lilly, eNeura, Novartis, Teva. Dr. Goadsby has received personal compensation in an editorial capacity for Journal Watch, Up-to-Date, Oxford Univeristy Press, Massachusetts Medical Society, Walters Kluwer. Dr. Goadsby has received compensation for serving on the Board of Directors of Trigemina Inc. Dr. Goadsby has received research support from Amgen.

Joshua Goldstein Dr. Goldstein has received research funding from Pfizer, Boehringer Ingelheim, and Portola.

Ludwig Kappos, MD, FAAN All payments have been transferred to a research account of the University Hospital Basel -> NO Personal compensation. To institution (University Hospital Basel) license fees for Neurostatus products and grants from Bayer, Biogen, Merck, Novartis, Roche, Teva, Roche Research Foundation, Swiss MS Society, and Swiss National Research Foundation.

Miia Kivipelto, MD Dr. Kivipelto has received personal compensation for activities with Pfizer as a speaker.

Jerry R. Mendell, MD, FAAN Dr. Mendell has received personal compensation for activities with AveXis, Inc. and Sarepta Therapeutics as a consultant. Dr. Mendell has received research support from Sarepta Therapeutics Inc. and AveXis, Inc.

Scott Powers, PhD Dr. Powers has nothing to disclose.

Gil I. Wolfe, MD, FAAN Dr. Wolfe has received personal compensation for activities with Grifols, Baxter, Syntimmune, and ArgenX. Dr. Wolfe has received research support from Nufactor.

Register Now

Related Courses

Monday April 23, 2018

7:00 AM-9:00 AM
C61 Therapy of Neuromuscular Disease: ALS, Inflammatory Neuropathies and Myopathies, and Myasthenia Gravis Michael Weiss MD, FAAN
C62 Child Neurology I: Pediatric Stroke, MS/Autoimmune Marc Patterson MD, FAAN, FRACP
C64 Update on Medical Management of Stroke Natalia Rost MD, MPH, FAAN
C66 Cognitive Impairment due to Alzheimer's Disease: Using Old Skills and New Tools for Diagnosis and Treatment David Knopman MD, FAAN
C65 Video EEG: Name That Spell Amy Crepeau MD
1:00 PM-3:00 PM
C75 Therapeutic Temperature Modulation in the ICU Stephan Mayer MD
C70 Child Neurology II: Epilepsy and Neuromuscular Marc Patterson MD, FAAN, FRACP
C71 Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease I Jeffrey Gelfand MD, MAS, FAAN
C73 Clinical Approach to Muscle Disease I: Muscle Disorders and Rhabdomyolysis Tahseen Mozaffar MD, FAAN
C76 Comprehensive Migraine Education Program I: Diagnosis, Risk Factors, and Neurobiology Gretchen Tietjen MD
C77 Present and Future Biomarkers in Dementia: A Case-based Approach Jonathan Graff-Radford MD
C74 Epilepsy Surgery Update Stephan Schuele MD, FAAN
3:30 PM-5:30 PM
N2 Neuroscience in the Clinic: Antisense Oligonucleotide (ASO) Therapy John Day MD, PhD,
Richard Finkel MD
C85 Child Neurology III: Headache, TBI/Post-concussion Marc Patterson MD, FAAN, FRACP
C86 Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease II Jeffrey Gelfand MD, MAS, FAAN
C88 Clinical Approach to Muscle Disease II: Inflammatory Myopathies and Muscle Pathology Tahseen Mozaffar MD, FAAN
C89 Comprehensive Migraine Education Program II: Behavioral and Psychological Aspects, and Preventive and Acute Treatment Advances Gretchen Tietjen MD
C91 Chronic Traumatic Encephalopathy: Update Andrew Budson MD
C94 Spanish: Update CNS Infections and Tropical Medicine Oscar Del Brutto MD, FAAN

Tuesday April 24, 2018

7:00 AM-9:00 AM
C95 Status Epilepticus Stephan Schuele MD, FAAN
C96 Vascular Cognitive Impairment and Dementia: Current Status and Future Larry Goldstein MD, FAAN, FAHA
C97 Multiple Sclerosis Overview I: Clinical Pearls John Corboy MD, FAAN
1:00 PM-3:00 PM
N3 Neuroscience in the Clinic: Challenges in Genetic Diagnosis in Neurology Guy Rouleau MD, PhD,
Massimo Pandolfo MD, FAAN
C104 Critical Care EEG Monitoring Suzette LaRoche MD, FAAN
C105 Assessment and Management of Neuropsychiatric Symptoms in Neurocognitive Disorders Daniel Kaufer MD, FAAN
C106 Introduction to Primary Headache Disorders I: Migraine and Other Primary Headaches Including Tension-Type, Hypnic, Primary Stabbing and Nummular Headache Syndromes, Epicrania Fugax and Retinal Migraine Deborah Friedman MD, MPH, FAAN
C107 Multiple Sclerosis Overview II: Clinical Advances Scott Newsome DO, FAAN
C108 Neurologic Complications in Adults with Down Syndrome Andrea Gropman MD
C114 Cerebrovascular Disease I: Prevention Larry Goldstein MD, FAAN, FAHA
1:00 PM-5:30 PM
C118 EMG Skills Workshop: Basic Ezgi Tiryaki MD, FAAN
3:30 PM-5:30 PM
C129 Disorders of Motor Programming: The Apraxias and Action-Intentional Disorders Chalk Talk Kenneth Heilman MD, FAAN
C120 Introduction to Primary Headache Disorders II: Trigeminal Autonomic Cephalalgias and Other Primary Headaches Including New Daily Persistent Headache, Cough, Exercise, and Thunderclap Headaches Christopher Boes MD, FAAN
C121 Multiple Sclerosis Overview III: Basic and Translational Science Michael Racke MD
C122 Child Neurology: A Case-based Approach Elaine Wirrell MD, FAAN
C128 Cerebrovascular Disease II: Update on Guidance-Based Diagnosis and Management of Hemorrhagic Stroke Philip Gorelick MD, MPH, FAAN

Wednesday April 25, 2018

7:00 AM-9:00 AM
C136 Emergency and Inpatient Management of Migraine and Other Headache Disorders Stephanie Nahas MD, FAAN
C137 Clinical EEG I: Normal EEG, Normal Variants, and How to Avoid The Common Pitfall of Over-reading Selim Benbadis MD
C134 Neurocognitive Assessment for Neurologists Mario Mendez MD, PhD, FAAN
C135 Multiple Sclerosis Therapy: Disease-modifying Treatment I David Jones MD
C140 Integrating Sleep Medicine Concepts into Your Child Neurology Practice Suresh Kotagal MD, FAAN
C141 Mastering EMG Waveform Recognition Skills in Just Two Hours! Devon Rubin MD, FAAN
C132 Higher Cortical Visual Disorders: Case-based Review Sashank Prasad MD
9:15 AM-11:30 AM
PL5 Frontiers in Neuroscience Plenary Session
1:00 PM-3:00 PM
C155 Clinical EEG II: Focal, Diffuse, and Epileptiform Abnormalities in Adults Katherine Noe MD, PhD, FAAN
C144 Severe TBI: From ICU to Rehabilitation Susanne Muehlschlegel MD,MPH
C145 Non-Alzheimer's Dementia I: Frontotemporal Dementias Gil Rabinovici MD
C146 Multiple Sclerosis Therapy: Disease-modifying Treatment II John Rose MD, FAAN
C150 Cerebrovascular Disease III: Update on Neuroimaging Modalities and Endovascular Therapies for Acute Ischemic Stroke Philip Gorelick MD, MPH, FAAN
C154 Small Fiber Neuropathies: Sensory, Autonomic, and Both I: Focus on Autonomic Nervous System Christopher Gibbons MD, FAAN
3:30 PM-5:30 PM
C169 Clinical EEG III: Neonatal and Pediatric Nicholas Abend MD
C160 Non-Alzheimer's Dementia II: Lewy Body Dementias and Other Parkinsonian Dementias Gil Rabinovici MD
C161 Multiple Sclerosis Therapy: Symptom Management Jonathan Carter MD
C165 Cerebrovascular Disease IV: Telestroke Eric Anderson MD, PhD
C168 Small Fiber Neuropathies: Sensory, Autonomic, and Both II: Focus on Sensory Nervous System Christopher Gibbons MD, FAAN
C170 Spanish: Update on Epilepsy Therapy Andres Kanner MD, FAAN

Thursday April 26, 2018

7:00 AM-9:00 AM
C178 Clinical EMG I: Principles and Practice of NCS and Needle EMG Ruple Laughlin MD, FAAN
C171 Clinical Epilepsy I: Basics Tracey Milligan MD, FAAN
C174 Clinical Pearls in Autoimmune Neurology: Real World Cases Stacey Clardy MD, PhD
C180 Preventive Neurology: How Neurologists Can Improve Outcomes That Matter to Patients Joel Salinas MD
1:00 PM-3:00 PM
N5 Neuroscience in the Clinic: Treatment of Progressive Multiple Sclerosis Eric Klawiter MD,
Ellen Mowry MD, FAAN
C192 Assessment of Rapidly Progressive Dementias I: Overview, Prion Diseases, and Neurodegenerative Rapidly Progressive Dementia Michael Geschwind MD, PhD
C191 Clinical EMG II: Neuromuscular Junction Testing and Quantitative EMG Mark Bromberg MD, PhD, FAAN
C181 Clinical Epilepsy II: Considerations Across the Age Span Pediatrics, Pregnancy, and Elderly Barbara Jobst MD, FAAN
C183 Behavioral Neurology I: Network Anatomy of Behavior and Language Maria Gorno Tempini MD, PhD
C193 Practical Training in Injection Techniques in the Treatment of Headache Disorders Skills Workshop Morris Levin MD, FAAN
C194 Spanish: Update on Stroke Therapy Carlos Kase MD, FAAN, FAHA
3:30 PM-5:30 PM
C207 Assessment of Rapidly Progressive Dementias II: Autoimmune Encephalopathies and Infections Presenting as Rapidly Progressive Dementia Michael Geschwind MD, PhD
C205 Clinical EMG III: Nerve Conduction Criteria and Electrodiagnostic Approaches Mark Bromberg MD, PhD, FAAN
C196 Clinical Epilepsy III: Advanced (Status, Beyond AED, Video EEG) Tobias Loddenkemper MD
C197 Behavioral Neurology II: Memory and Attention Maria Gorno Tempini MD, PhD
C202 Endovascular Treatment of Acute Stroke and Cerebrovascular Disease Dileep Yavagal MD, FAAN
6:30 PM-9:30 PM
C209 Case Studies: Unusual Diagnostic and Management of Cases in Neuromuscular Disease Anne Connolly MD, FAAN
C213 Case Studies: Challenging Headache Cases Kathleen Digre MD, FAAN
C214 Case Studies in Behavioral Neurology: Focus on Frontotemporal Degeneration Daniel Kaufer MD, FAAN

MEMBER LOG IN

Forgot Password?